HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Interpretive Summary Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Menge, C. Articles by Dean-Nystrom, E. A. Search for Related Content PubMed PubMed Citation Articles by Menge, C. Articles by Dean-Nystrom, E. A.

Dexamethasone Depletes T Cells and Alters the Activation State and Responsiveness of Bovine Peripheral Blood Lymphocyte Subpopulations¹

C. Menge^*,2 and E. A. Dean-Nystrom

^* Institute for Hygiene and Infectious Diseases of Animals, Justus-Liebig-University, D-35392 Giessen, Germany
Pre-Harvest Food Safety and Enteric Diseases Research Unit, National Animal Disease Center, USDA Agricultural Research Service, Ames, IA 50010

² Corresponding author: christian.menge{at}vetmed.uni-giessen.de

Administration of dexamethasone (DEX) to cattle is commonly used in models of stress-induced effects on host defense, including models investigating interactions of microorganisms with their host. Much less is known about the effects of DEX on the adaptive immune response in cattle compared with other species. The objective of the present study was to characterize subsets of circulating lymphocytes in calves before and 48 h after the onset of parenteral DEX treatment. Treatment significantly reduced the overall percentage of circulating lymphocytes and disproportionately depleted the population of TCR⁺/CD8^– cells. Analysis within the CD8⁺ population of T cells revealed that DEX treatment also reduced the CD8^low subset of T cells coexpressing the activation marker ACT-2⁺. By contrast, DEX treatment did not affect the percentage of CD8^low/CD25⁺ cells, indicating that cells with a special activation state were affected. Dexamethasone treatment reduced the number of T cells but increased the percentages of CD14⁺ monocytes and activated CD25⁺ cells (both CD4^– and CD4⁺) in peripheral blood mononuclear cell (PBMC) preparations. Although DEX treatment reduced the overall proliferative capacity of PBMC, it enhanced the relative number of proliferating CD4⁺ lymphocytes. Lower levels of mRNA for several Th-prototype cytokines (IL-2, IFN-β, IL-4, transforming growth factor-β) were detected in short-term PBMC cultures established from DEX-treated calves compared with PBMC cultures from control calves; the amount of il-10 transcripts, however, was unaffected. Results of the study reported here clearly show that DEX treatment does not uniformly suppress the bovine immune system but has differential effects on lymphocyte sub-populations and functions. This information must be considered when using DEX treatment as a bovine stress model.

Key Words: dexamethasone • in vivo • lymphocyte • cattle

This article has been cited by other articles:

				E. A. Dean-Nystrom, W. C. Stoffregen, B. T. Bosworth, H. W. Moon, and J. F. Pohlenz Early Attachment Sites for Shiga-Toxigenic Escherichia coli O157:H7 in Experimentally Inoculated Weaned Calves Appl. Envir. Microbiol., October 15, 2008; 74(20): 6378 - 6384. [Abstract] [Full Text] [PDF]